Evidence map›Paper›PMID 31828232›Full record

ArticleIBRO reports2019

Delta-9-tetrahydrocannabinol reduces the performance in sensory delayed discrimination tasks. A pharmacological-fMRI study in healthy volunteers.

Carmen Walter, Bruno G Oertel, Lisa Felden, Ulrike Nöth, Ralf Deichmann, Jörn Lötsch

Open access · goldAbstract read
In one paragraph

Article in IBRO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carmen WalterInstitute of Clinical Pharmacology, Goethe - University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.
Bruno G OertelInstitute of Clinical Pharmacology, Goethe - University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.
Lisa FeldenInstitute of Clinical Pharmacology, Goethe - University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.
Ulrike NöthBrain Imaging Center, Goethe - University, Schleusenweg 2 - 16, 60528, Frankfurt am Main, Germany.
Ralf DeichmannBrain Imaging Center, Goethe - University, Schleusenweg 2 - 16, 60528, Frankfurt am Main, Germany.
Jörn LötschInstitute of Clinical Pharmacology, Goethe - University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCannabis proofed to be effective in pain relief, but one major side effect is its influence on memory in humans. Therefore, the role of memory on central processing of nociceptive information was investigated in healthy volunteers.

methodsIn a placebo-controlled cross-over study including 22 healthy subjects, the effect of 20 mg oral Δ

resultsFor each nociceptive stimulus pair, the second stimulus was associated with stronger and more extended brain activations than the first stimulus. These differences disappeared after THC administration. The THC effects were mainly located in two clusters comprising the insula and inferior frontal cortex in the right hemisphere, and the caudate nucleus and putamen bilaterally. These cerebral effects were accompanied in the DSDT by a significant reduction of correct ratings from 41.61% to 37.05% after THC administration (rm-ANOVA interaction "drug" by "measurement": F (1,21) = 4.685, p = 0.042). Rating performance was also reduced for the visual DSDT (69.87% to 54.35%; rm-ANOVA interaction of "drug" by "measurement": F (1,12) = 13.478, p = 0.003) and reflected in a reduction of stimulus-related brain deactivations in the bilateral angular gyrus.

conclusionsResults suggest that part of the effect of THC on pain may be related to memory effects. THC reduced the performance in DSDT of nociceptive and visual stimuli, which was accompanied by significant effects on brain activations. However, a pain specificity of these effects cannot be deduced from the data presented.

Indexed as

CannabisClincial pharmacologyHumanPainPharmacometricsPharm-fMRI

Identifiers

PMID31828232
PMCPMC6889084
OpenAlexW2986962812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.